Table 1.

Adverse events in Cohort 1

Subjects	Concentration (one drop once; μg/ml)	Ocular AEs reported (no. of patients; severity)	Systemic AEs reported
3 rhNGF	0.5	None	None
3 rhNGF	5	Warm feeling, left eye (n = 1; mild)	None
3 rhNGF	20	Feeling of pressure, both eyes (n = 1; mild)	Common cold (n = 1; mild)

AEs adverse events, rhNGF human recombinant nerve growth factor